Clinical Trial Update: Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating single- or two-dose RSV F vaccine regimens with or without aluminum phosphate or Matrix-M1 adjuvants in clinically-stable older …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Disease
• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Viruses | Phase 2 | Status: COMPLETED